Table 3.

Correlations between metabolic parameters from FDG PET/CT scans and clinical prognostic parameters.

	Grade	Tumor size	N status	M status	Stage	ER	PR	c-erbB-2	p53	Ki-67
	p	p	p	p	p	p	p	p	p	p
Maximal SUVbt	0.0262*	0.0012*	NS	NS	NS	NS	NS	NS	NS	NS
Maximal SUVln	NS	NS	<0.0001*	0.0005*	<0.0001*	NS	NS	NS	NS	NS
MTVbt	0.0003*	0.0332*	NS	NS	NS	NS	NS	NS	NS	NS
MTVwb	NS	0.0017*	<0.0001*	0.0006*	<0.0001*	NS	NS	NS	NS	NS
TLGbt	0.0004*	0.0047*	NS	NS	0.0466*	NS	NS	NS	NS	NS
TLGwb	NS	0.0012*	<0.0001*	0.0008*	<0.0001*	NS	NS	NS	NS	NS
Contrast	NS	NS	NS	NS	NS	NS	NS	NS	NS	NS
Homogeneity	0.0005*	0.0382*	NS	NS	NS	NS	NS	NS	NS	NS
Dissimilarity	0.0017*	0.0225*	NS	NS	NS	NS	NS	NS	NS	NS
Second angular moment	0.0007*	0.0335*	NS	NS	NS	NS	NS	NS	NS	NS
SUV skewness	0.0421*	NS	NS	NS	NS	NS	NS	NS	NS	NS
SUV kurtosis	0.0034*	NS	NS	NS	NS	NS	NS	NS	NS	NS
SUV variance	NS	0.0015*	NS	NS	NS	NS	NS	NS	NS	NS
SUV mean	NS	0.0027*	NS	NS	NS	NS	NS	NS	NS	NS
SUV entropy	NS	NS	NS	NS	NS	NS	NS	0.0446*	NS	NS

*Statistically significant.

NS: not statistically significant.

SUVbt: standardized uptake value of breast tumor.

SUVln: standardized uptake value of axillary lymph node.

MTVbt: metabolic tumor volume of breast tumor.

MTVwb: metabolic tumor volume of whole body lesions.

TLGbt: total lesion glycolysis of breast tumor.

TLGwb: total lesion glycolysis of whole body lesions.

ER: estrogen receptor.

PR: progesterone receptor.

c-erbB-2: human epidermal growth factor receptor 2.